ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 7 filers reported holding ENLIVEX THERAPEUTICS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,000 | – | 418 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 15,000 | $64,000 | 0.09% |
Lee Capital Holdings LLC | 11,805 | $50,000 | 0.07% |
Susquehanna International Group Ltd. | 20,299 | $85,000 | 0.03% |
Compagnie Lombard Odier SCmA | 50,000 | $211,000 | 0.01% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $55,000 | 0.00% |
OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 750 | $3,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 18,054 | $77,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 484 | $2,000 | 0.00% |